摘要
目的:腹膜透析患者使用血管紧张素抑制剂与否对患者生存率和技术生存率的影响。方法:回顾性分析2008年1月-2013年1月在笔者所在医院规律随访的维持性腹膜透析患者,分为使用血管紧张素抑制剂组(ACEI/ARB组)148例,未使用(非ACEI/ARB组)100例,对比有无使用血管紧张素抑制剂对生存率的影响。结果:ACEI/ARB组患者存活率87.2%,非ACEI/ARB组56.0%(P<0.05),两组对比生存曲线显示明显差异;且ACEI/ARB组技术生存率也明显好于非ACEI/ARB组(77.0%vs 46.0%,P<0.05)。结论:长期使用血管紧张素抑制剂可改善腹膜透析患者生存率及技术生存率。
Objective：The present study was to investigate the effect of angiotensin inhibitor on survival rate in continuous ambulatory peritoneal dialysis patients.Method：To retrospective study in patients who had undergone continuous ambulatory peritoneal dialysis（CAPD） from January 2008 to January 2013. Patients were divided into two groups,ACEI/ARB group 148 cases and non-ACEI/ARB group 100 cases,and survival rate was calculated.Result：There was significant statistical difference in patients survival rates between ACEI/ARB group and non-ACEI/ARB group（87.2%vs 56.0%,P〈0.05）.Meanwhile patients in ACEI/ARB group had better technique survival rate compared with patients in non-ACEI/ARB group（77.0%vs 46.0%,P〈0.05）.Conclusion：Long time using AECI/ARB is effective for patient and technique survival rates.
出处
《中外医学研究》
2014年第5期18-19,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
血管紧张素抑制剂
腹膜透析
生存率
Angiotensin inhibitor
Peritoneal dialysis
Survival rate
